USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Global Pharmaceutical Industry Outlook, 2023
Global Pharmaceutical Industry Outlook, 2023
Transformative Megatrends are Expanding the Vendor Ecosystem
27-Mar-2023
Global
Market Outlook
Description
This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the Asia-Pacific, Latin America, and the Rest of the World. Inflation will continue to be a pressing challenge for the pharmaceutical industry in 2023, affecting returns on investment. Pharmaceutical companies will continue to shift towards regional rather than global suppliers to ensure geographic proximity and a smoother, more reliable supply chain. There will be a strong focus on environmental, social, and governance (ESG) commitments and supply-chain digitalization through lighthouse manufacturing techniques, decentralized clinical trial (DCT) approaches, and the application of artificial intelligence (AI). The study segments the pharmaceutical industry into two key segments, namely, chemicals/small molecules and biologics. It covers the following:
• An overview of the pharmaceutical industry
• Revenue forecasts by segment
• Top 5 predictions for the industry for 2023 and beyond
• Key macro and micro trends driving the future of the industry
• Research and development (R&D) expenditure and key therapeutic areas for 2023 and beyond
• Growth opportunities emerging from this space for stakeholders and market players to leverage
Author: Surbhi Gupta
Table of Contents
Key Highlights
Top Predictions for 2023
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Global Pharmaceutical Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Segmentation and Scope
Key Trend 1: Adoption of Lighthouse Manufacturing Techniques
Key Trend 1: Adoption of Lighthouse Manufacturing Techniques (continued)
Key Trend 2: Increased Focus on Fulfilling ESG Commitments
Key Trend 2: Increased Focus on Fulfilling ESG Commitments (continued)
Key Trend 3: Increased Application of AI across the Pharma Value Chain
Key Trend 3: Increased Application of AI across the Pharma Value Chain (continued)
Key Trend 4: Intensification of Skilled Workforce Challenges
Key Trend 4: Intensification of Skilled Workforce Challenges (continued)
Global Pharmaceutical Industry: R&D Expenditure Outlook
Global Drug Development Pipeline by Clinical Phase
Key Therapeutic Areas Outlook
Top 5 Global Economic Highlights of 2022
Top 5 Global Economic Highlights of 2023
Global GDP Growth Expectations
Recessionary/Slowdown Expectations for Major Economies
Global GDP Growth Snapshot
Advanced Economy Predictions for 2023
Emerging Market Economy Predictions for 2023
2023 Regional Risks and Policy Direction
2023 Top Growth Opportunities by Region
Right Shoring vs. Reshoring: Impact Analysis
Right Shoring vs. Reshoring: Impact Analysis (continued)
Rising Inflation: Impact Analysis
Rising Inflation: Impact Analysis (continued)
Global Pharmaceutical Industry: Historic Sales and Forecast
Segment Performance: Historic Sales and Forecast
Revenue Forecast by Region
Regulatory Regional Trends: North America
Regulatory Regional Trends: Europe
Regulatory Regional Trends: Asia-Pacific, Latin America, the Middle East and Africa
Prediction 1
Prediction 2
Prediction 3
Prediction 4
Prediction 5
Small Molecules Snapshot, 2023
Small Molecules: Companies to Watch
Biologics Snapshot, 2023
Biologics Snapshot: Companies to Watch
Growth Opportunity 1: Drug and Software-as-a-Medical-Device (SaMD) Combination Products and Platforms
Growth Opportunity 1: Drug and Software-as-a-Medical-Device (SaMD) Combination Products and Platforms (continued)
Growth Opportunity 2: Dual and Multi-targeting Antibodies for Immuno-oncology
Growth Opportunity 2: Dual and Multi-targeting Antibodies for Immuno-oncology (continued)
Growth Opportunity 3: Strategic CGT Partnerships between Academia, CDMOs, and Biopharma Companies in the EU
Growth Opportunity 3: Strategic CGT Partnerships between Academia, CDMOs, and Biopharma Companies in the EU (continued)
Key Conclusions
Market Definition: Pharmaceuticals and Biotechnology
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
Growth dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Outlook |
|---|---|
| Author | Surbhi Gupta |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Pharmaceutical Market Trends |
| Keyword 2 | Pharmaceutical Market Forecast |
| Keyword 3 | future trends in pharmaceutical industry |
| Podcast | No |
| Predecessor | PCC8-01-00-00-00 |
| WIP Number | PE5D-01-00-00-00 |
